✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Sequent Scientific Ltd.

SEQUENT

Market Cap
₹3,709 Cr.
P/E
318.44

Sequent Scientific Ltd.

  • Sequent Scientific
  • Gufic Biosciences
  • Orchid Pharma
  • TJI Pharma - Small Cap
FAQs on Sequent Scientific Ltd. Shareprice

Sequent Scientific has given lower returns compared to its competitors.
Sequent Scientific has grown at ~12.17% over the last 7yrs while peers have grown at a median rate of 14.53%

Sequent Scientific is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Sequent Scientific is 318, while 3 year average PE is 121.
Also latest EV/EBITDA of Sequent Scientific is 27.65 while 3yr average is 153.

View FAQ's On Business
Growth Table
  • Sequent Scientific Ltd.
  • Gufic Biosciences
  • Orchid Pharma
Balance Sheet
  • Sequent Scientific Ltd.
  • Gufic Biosciences
  • Orchid Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Sequent Scientific Ltd.
  • Gufic Biosciences
  • Orchid Pharma
Cash Flow
  • Sequent Scientific Ltd.
  • Gufic Biosciences
  • Orchid Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Sequent Scientific Ltd.
  • Gufic Biosciences
  • Orchid Pharma
Quarterly Results
  • Sequent Scientific Ltd.
  • Gufic Biosciences
  • Orchid Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Sequent Scientific Ltd. Financials

Balance sheet of Sequent Scientific is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Sequent Scientific is increasing.
Latest debt of Sequent Scientific is ₹378 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹312 Crs.

Yes, profit is increasing.
The profit of Sequent Scientific is ₹23.15 Crs for TTM, -₹35.87 Crs for Mar 2024 and -₹121.16 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sequent Scientific latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech